Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Peptide Receptor Radionuclide Therapy (PRRT) Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Gastroenteropancreatic Neuroendocrine Tumor
    • 1.4.3 Foregut Neuroendocrine Tumor
    • 1.4.4 Midgut Neuroendocrine Tumor
    • 1.4.5 Hindgut Neuroendocrine Tumor
  • 1.5 Market by Application
    • 1.5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Retail Pharmacies
    • 1.5.4 Online Pharmacies
  • 1.6 Coronavirus Disease 2019 (Covid-19): Peptide Receptor Radionuclide Therapy (PRRT) Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Peptide Receptor Radionuclide Therapy (PRRT) Industry
      • 1.6.1.1 Peptide Receptor Radionuclide Therapy (PRRT) Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Peptide Receptor Radionuclide Therapy (PRRT) Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Peptide Receptor Radionuclide Therapy (PRRT) Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Perspective (2015-2026)
  • 2.2 Peptide Receptor Radionuclide Therapy (PRRT) Growth Trends by Regions
    • 2.2.1 Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Peptide Receptor Radionuclide Therapy (PRRT) Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Peptide Receptor Radionuclide Therapy (PRRT) Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Market Size
    • 3.1.1 Global Top Peptide Receptor Radionuclide Therapy (PRRT) Players by Revenue (2015-2020)
    • 3.1.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio
    • 3.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Peptide Receptor Radionuclide Therapy (PRRT) Revenue in 2019
  • 3.3 Peptide Receptor Radionuclide Therapy (PRRT) Key Players Head office and Area Served
  • 3.4 Key Players Peptide Receptor Radionuclide Therapy (PRRT) Product Solution and Service
  • 3.5 Date of Enter into Peptide Receptor Radionuclide Therapy (PRRT) Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Historic Market Size by Type (2015-2020)
  • 4.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Type (2021-2026)

5 Peptide Receptor Radionuclide Therapy (PRRT) Breakdown Data by Application (2015-2026)

  • 5.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)
  • 5.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
  • 6.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in North America (2019-2020)
  • 6.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
  • 6.4 North America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
  • 7.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Europe (2019-2020)
  • 7.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
  • 7.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

8 China

  • 8.1 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
  • 8.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in China (2019-2020)
  • 8.3 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
  • 8.4 China Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
  • 9.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Japan (2019-2020)
  • 9.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
  • 9.4 Japan Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
  • 10.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

11 India

  • 11.1 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
  • 11.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in India (2019-2020)
  • 11.3 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
  • 11.4 India Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size (2015-2020)
  • 12.2 Peptide Receptor Radionuclide Therapy (PRRT) Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Type (2015-2020)
  • 12.4 Central & South America Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Novartis
    • 13.1.1 Novartis Company Details
    • 13.1.2 Novartis Business Overview and Its Total Revenue
    • 13.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Introduction
    • 13.1.4 Novartis Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020))
    • 13.1.5 Novartis Recent Development
  • 13.2 ITM Solucin
    • 13.2.1 ITM Solucin Company Details
    • 13.2.2 ITM Solucin Business Overview and Its Total Revenue
    • 13.2.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Introduction
    • 13.2.4 ITM Solucin Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
    • 13.2.5 ITM Solucin Recent Development
  • 13.3 National Institutes of Health
    • 13.3.1 National Institutes of Health Company Details
    • 13.3.2 National Institutes of Health Business Overview and Its Total Revenue
    • 13.3.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Introduction
    • 13.3.4 National Institutes of Health Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
    • 13.3.5 National Institutes of Health Recent Development
  • 13.4 Australasian Gastro-Intestinal Trials Group
    • 13.4.1 Australasian Gastro-Intestinal Trials Group Company Details
    • 13.4.2 Australasian Gastro-Intestinal Trials Group Business Overview and Its Total Revenue
    • 13.4.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Introduction
    • 13.4.4 Australasian Gastro-Intestinal Trials Group Revenue in Peptide Receptor Radionuclide Therapy (PRRT) Business (2015-2020)
    • 13.4.5 Australasian Gastro-Intestinal Trials Group Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Peptide Receptor Radionuclide Therapy (PRRT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide Receptor Radionuclide Therapy (PRRT) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Novartis
    ITM Solucin
    National Institutes of Health
    Australasian Gastro-Intestinal Trials Group
    ...

    Market segment by Type, the product can be split into
    Gastroenteropancreatic Neuroendocrine Tumor
    Foregut Neuroendocrine Tumor
    Midgut Neuroendocrine Tumor
    Hindgut Neuroendocrine Tumor
    Market segment by Application, split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Peptide Receptor Radionuclide Therapy (PRRT) status, future forecast, growth opportunity, key market and key players.
    To present the Peptide Receptor Radionuclide Therapy (PRRT) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Peptide Receptor Radionuclide Therapy (PRRT) are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now